The capacity of HDL to stimulate cholesterol efflux is maintained in subjects with and without low HDL-C treated with torcetrapib

被引：0
|
作者：
Bamberger, M. J.
Moya, M. D.
Durham, K.
Shear, C. L.
Nguyen, T. T.
Revkin, J. H.
Rothblat, G. H.
机构：
[1] Pfizer Global Res & Dev, Groton, CT USA
[2] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2006年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1567-5688(06)82220-8
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
ThP16262
引用
收藏
页码：550 / 550
页数：1
相关论文
共 50 条
  • [1] HDL-C RELATES TO MARKERS OF ABSORPTION BUT NOT OF SYNTHESIS OF CHOLESTEROL: STUDY IN SUBJECTS WITH LOW VS. HIGH HDL-C
    Nunes, V. Sutti
    Leanca, C. C.
    Pnazoldo, N. B.
    Correa, D. F.
    Nakandakare, E. R.
    de Faria, E. C.
    Quintao, E. C. R.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 82 - 83
  • [2] Serum, but not monocyte macrophage foam cells derived from low HDL-C subjects, displays reduced cholesterol efflux capacity
    Nakanishi, Shuhei
    Vikstedt, Riikka
    Soderlund, Sanni
    Lee-Rueckert, Miriam
    Hiukka, Anne
    Ehnholm, Christian
    Muilu, Mikko
    Metso, Jari
    Naukkarinen, Jussi
    Palotie, Leena
    Kovanen, Petri T.
    Jauhiainen, Matti
    Taskinen, Marja-Riitta
    [J]. JOURNAL OF LIPID RESEARCH, 2009, 50 (02) : 183 - 192
  • [3] HDL cholesterol efflux capacity
    Kang, Seema
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (02): : 101 - 101
  • [4] Serum Cholesterol Efflux Capacity, a Measure of HDL-C Quality, Varies According to Coronary Artery Disease Status Independently of HDL-C Quantity
    Khera, Amit V.
    Rodrigues, Amrith
    de la Llera-Moya, Margarita
    Rothblat, George H.
    Rader, Daniel J.
    [J]. CIRCULATION, 2009, 120 (18) : S469 - S469
  • [5] HDL-C concentration is related to markers of absorption and of cholesterol synthesis: Study in subjects with low vs. high HDL-C
    Nunes, V. S.
    Leanca, C. C.
    Panzoldo, N. B.
    Parra, E.
    Cazita, P. M.
    Nakandakare, E. R.
    de Faria, E. C.
    Quintao, E. C. R.
    [J]. CLINICA CHIMICA ACTA, 2011, 412 (1-2) : 176 - 180
  • [6] Neutrophil/HDL-C, Lymphocyte/HDL-C and Monocyte/HDL-C in subjects with asymptomatic carotid atherosclerosis
    Caimi, Gregorio
    Lo Presti, Rosalia
    Urso, Caterina
    Brucculeri, Salvatore
    Carlisi, Melania
    [J]. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2024, 88 (01) : 1 - 11
  • [7] Hdl Cholesterol Efflux Capacity is Inversely Associated With Incident Chd Events Independent of Hdl-c and Apoa-i Concentrations
    Saleheen, Danish
    Scott, Robert
    Javad, Sunda
    Zhao, Wei
    Rodrigues, Amrith
    Picataggi, Antonino
    Lukmanova, Daniya
    Mucksavage, Megan
    Luben, Robert
    Khaw, Kay-Tee
    Billheimer, Jeffery
    Wareham, Nick
    Rader, Daniel J.
    [J]. CIRCULATION, 2014, 130
  • [8] Should low high-density lipoprotein cholesterol (HDL-C) be treated?
    Toth, Peter R.
    Barylski, Marcin
    Nikolic, Dragana
    Rizzo, Manfredi
    Montalto, Giuseppe
    Banach, Maciej
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 28 (03) : 353 - 368
  • [9] FARNESOID X RECEPTOR ACTIVATION LOWERS HDL-C BUT INCREASES ABCA1-SPECIFIC SERUM HDL CHOLESTEROL EFFLUX CAPACITY
    Vaisar, T.
    Wimberger, J.
    Irwin, A.
    Vallim, T.
    [J]. ATHEROSCLEROSIS, 2019, 287 : E11 - E11
  • [10] CETP inhibition in humans by torcetrapib maintains the cholesterol efflux potential of HDL
    Bamberger, MJ
    Moya, M
    Durham, K
    Shear, CL
    Nguyen, TT
    Revkin, JH
    Rothblat, G
    [J]. CIRCULATION, 2005, 112 (17) : U235 - U235
12345